Mayo Clinic to test vaccine designed to provide immune response against early breast lesions
JACKSONVILLE, Fla. ? Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional therapy of surgery and possibly hormonal therapy and radiation. Now, Mayo Clinic researchers are about to test a vaccine [...]
Source: Mayo Clinic Florida News - Category: Hospital Management Source Type: news
More News: Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Hormonal Therapy | Hormones | Hospital Management | Vaccines | Women